Lilly applies for Alzheimer's drug's US approval after trial success

Sun Herald Business

Jul 17, 2023

Eli Lilly & Co. said it applied for full U.S. approval of its Alzheimer's disease drug that's expected to compete with Eisai Co.'s Leqembi as the U.S. drugmaker revealed details ..…